Abstract
Ensuring optimal bone accrual and assessing bone health measures when concerns arise are important aspects of adolescent health care. This chapter reviews laboratory assessments which may be considered, including available normative data, which laboratory assessments are most useful in the initial evaluation of common disorders and concerns, and when a referral to an endocrinologist or other bone specialist should be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DiMeglio LA, Imel EA. Calcium and phosphate: hormonal regulation and metabolism. In: Burr DB, Allen MR, editors. Basic and applied bone biology. San Diego: Academic Press; 2014. p. 261–82.
Goltzman D. Approach to hypercalcemia. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext. MDText.com: South Dartmouth; 2000.
Sharratt CL, Gilbert CJ, Cornes MC, Ford C, Gama R. EDTA sample contamination is common and often undetected, putting patients at unnecessary risk of harm. Int J Clin Pract. 2009;63(8):1259–62.
Richmond W, Colgan G, Simon S, Stuart-Hilgenfeld M, Wilson N, Alon US. Random urine calcium/osmolality in the assessment of calciuria in children with decreased muscle mass. Clin Nephrol. 2005;64(4):264–70.
Ghazali S, Barratt TM. Urinary excretion of calcium and magnesium in children. Arch Dis Child. 1974;49(2):97–101.
Jones AN, Shafer MM, Keuler NS, Crone EM, Hansen KE. Fasting and postprandial spot urine calcium-to-creatinine ratios do not detect hypercalciuria. Osteoporos Int. 2012;23(2):553–62.
Metz MP. Determining urinary calcium/creatinine cut-offs for the paediatric population using published data. Ann Clin Biochem. 2006;43(Pt 5):398–401.
Kiessling SG, Goebel J, Somers MJG. Pediatric nephrology in the ICU. Berlin: Springer; 2009.
Penido MG, Alon US. Phosphate homeostasis and its role in bone health. Pediatr Nephrol. 2012;27(11):2039–48.
Shaw N, Hogler W. Biochemical markers of bone metabolism. In: Glorieux FH, Pettifor JM, Juppner H, editors. Pediatric bone. 2nd ed. Amsterdam: Elsevier/Academic Press; 2012. p. 361–81.
Manghat P, Sodi R, Swaminathan R. Phosphate homeostasis and disorders. Ann Clin Biochem. 2014;51(Pt 6):631–56.
Payne RB. Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem. 1998;35(Pt 2):201–6.
de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
Brown EM, Chen CJ. Calcium, magnesium and the control of PTH secretion. Bone Miner. 1989;5(3):249–57.
Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257–72.
Ayuk J, Gittoes NJ. How should hypomagnesaemia be investigated and treated? Clin Endocrinol. 2011;75(6):743–6.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab. 2016;101(2):394–415.
Shieh A, Chun RF, Ma C, et al. Effects of high-dose vitamin D2 versus D3 on total and free 25-hydroxyvitamin D and markers of calcium balance. J Clin Endocrinol Metab. 2016;101(8):3070–8.
Binkley N, Krueger DC, Morgan S, Wiebe D. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin Chim Acta. 2010;411(23–24):1976–82.
Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58(3):531–42.
Binkley N, Dawson-Hughes B, Durazo-Arvizu, Thamm M, Tian L, Merkel JM, Jones JC, Carter GD, Sempos CT. Vitamin D measurement standardization: the way out of the chaos. J Steroid Biochem Mol Biol. 2017;173:117–21.
Zittermann A, Ernst JB, Becker T, et al. Measurement of circulating 1,25-dihydroxyvitamin D: comparison of an automated method with a liquid chromatography tandem mass spectrometry method. Int J Anal Chem. 2016;2016:8501435.
Endocrine Society. Choosing wisely: don’t routinely measure 1,25-dihydroxyvitamin D unless the patient has hypercalcemia or decreased kidney function. 2013. Available at: http://www.choosingwisely.org/clinician-lists/endocrine-society-vitamin-d-testing/. Accessed Oct 2017.
Martin KJ, Akhtar I, Gonzalez EA. Parathyroid hormone: new assays, new receptors. Semin Nephrol. 2004;24(1):3–9.
D’Amour P. Circulating PTH molecular forms: what we know and what we don’t. Kidney Int Suppl. 2006;102:S29–33.
Martin TJ. Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases. Physiol Rev. 2016;96(3):831–71.
Chew CK, Clarke BL. Biochemical testing relevant to bone. Endocrinol Metab Clin N Am. 2017;46(3):649–67.
Saraff V, Narayanan VK, Lawson AJ, Shaw NJ, Preece MA, Hogler W. A diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia. J Pediatr. 2016;172:181–186 e181.
Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med. 2013;11:201.
Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012;318(9):1040–8.
Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 2004;65(1):1–14.
El-Maouche D, Dumitrescu CE, Andreopoulou P, et al. Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type. Osteoporos Int. 2016;27(7):2345–53.
Folsom LJ, Imel EA. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep. 2015;13(2):78–87.
Gelfand IM, Eugster EA, DiMeglio LA. Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case series. J Pediatr. 2006;149(6):877–80.
Lietman SA, Germain-Lee EL, Levine MA. Hypercalcemia in children and adolescents. Curr Opin Pediatr. 2010;22(4):508–15.
Attie MF, Gill JR Jr, Stock JL, et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest. 1983;72(2):667–76.
Hendy GN, Guarnieri V, Canaff L. Calcium-sensing receptor and associated diseases. Prog Mol Biol Transl Sci. 2009;89:31–95.
Kelly A, Levine M. Disorders of calcium, phosphate, parathyroid hormone and vitamin D. In: Kappy M, Allen D, Geffner M, editors. Pediatric practice: endocrinology. Springfield: Thomas Publisher; 2009. p. 191–256.
Root AW, Diamond FB. Chapter 18 – Disorders of mineral homeostasis in children and adolescents. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: Saunders; 2014. p. 734–845.e731.
Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KLA. Clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381–8.
Bohm NM, Hoover KC, Wahlquist AE, Zhu Y, Velez JC. Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B. Antimicrob Agents Chemother. 2015;59(11):6816–23.
Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–64.
Ferrari S, Bianchi ML, Eisman JA, et al. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int. 2012;23(12):2735–48.
Acknowledgment
The authors would like to thank Dr. Erik Imel for his thoughtful review of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Neyman, A., DiMeglio, L.A. (2018). Bone Health Laboratory Assessments. In: Pitts, S., Gordon, C. (eds) A Practical Approach to Adolescent Bone Health . Springer, Cham. https://doi.org/10.1007/978-3-319-72880-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-72880-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72879-7
Online ISBN: 978-3-319-72880-3
eBook Packages: MedicineMedicine (R0)